• FirefoxTry Yahoo Finance on Firefox »
  •  Dow up 0.08% Nasdaq up 0.28%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow up 0.08% Nasdaq up 0.28%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    Feb 27 182.88 +1.59 +0.88% 180.13 183.15 660,295 1,059,960 54.09B Sparkline Chart Chart, News, Stats, Options, Board
    Feb 27 60.18 +0.04 +0.07% 60.07 60.50 20,970 40,634 - Sparkline Chart Chart, News, Options, Board
    - - 0.00 0.00% - - 0 989,170 - Sparkline Chart Chart, News, Options, Board
    Feb 27 54.87 -0.23 -0.42% 54.59 55.12 792,326 1,140,070 6.35B Sparkline Chart Chart, News, Stats, Options, Board
    {"s" : "shpg,indl,rden,ptc","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Monday February 27, 2017
    Revlon teams up with Amazon on heels of 'Love Project' at American City Business Journals03:00pm EST
    Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia06:00am EST
    argenx announces extension of therapeutic antibody alliance with Shire GlobeNewswire01:01am EST
    Friday February 24, 2017
    SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online04:42pm EST
    NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes01:21pm EST
    Patient Dies In Roche Hemophilia Study at Investopedia10:02am EST
    Blog Coverage Novartis Gains Priority Review from the FDA for its Cancer Drug Zykadia as a Frontline Treatment for ALK-positive Non-Small Cell Lung Cancer Accesswire08:15am EST
    CHMP Recommends EU Conditional Marketing Authorisation for NatparĀ® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism PR Newswire07:17am EST
    Thursday February 23, 2017
    Revlon Is Advertising on Amazon Boxes at Bloomberg12:25pm EST
    Biotech Movers: Shire Rises on Encouraging Angioedema Results at TheStreet09:20am EST
    New England Journal of Medicine Publishes Phase 1b Results for Shire's Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease PR Newswire04:11am EST
    Shire Launches 'Rare Count' Campaign to Personalize the Global Impact of Rare Diseases PR Newswire02:00am EST
    Wednesday February 22, 2017
    SHIRE PLC Files SEC form 10-K, Annual Report EDGAR Online04:56pm EST
    Momenta Tops Q4 Earnings, Shares Down on Warning Letter Zacks03:13pm EST
    Shire Plc :SHPG-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 at Capital Cube11:55am EST
    Momenta 4Q Net 60 Cents a Share at Investopedia11:05am EST
    Tuesday February 21, 2017
    SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online02:01pm EST
    Shire Plc :SHPG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017 at Capital Cube09:27am EST
    PTC and Deloitte Announce Plans to Accelerate Internet of Things Adoption and Innovation for Businesses Business Wire09:00am EST
    Monday February 20, 2017
    3 Stocks to Invest in Big Pharma at Motley Fool09:57am EST
    3 Stocks to Invest in Big Pharma at Motley Fool09:57am EST
    Friday February 17, 2017
    Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View Zacks02:04pm EST
    Shire PLC 4Q Earnings, Revenue Beat Street at Investopedia01:50pm EST
    SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online01:08pm EST
    Thursday February 16, 2017
    Drugmaker Shire Tops Q4 Views; Stock Pops To Six-Week High at Investor's Business Daily04:28pm EST